康圣环球基因技术有限公司（09960）于2026年3月4日披露截至2026年2月28日止月份之证券变动月报，报告期内公司普通股股本结构及变动情况维持稳定。
根据公告，法定注册股本于月初及月末均为2,000,000,000股普通股，每股面值0.00025美元，对应总额500,000美元，期间无增减变动。
公司已发行股份数量（不含库存股）为1,034,245,964股，库存股份数量为7,064,000股，合计1,041,309,964股，与上月相比无新增发行、回购或注销活动。期权方面，首次公开发售前股票激励计划共2,643,332份期权在本月内未发生增减变化，首次公开发售后购股权计划虽无当月增减，但可供行使的潜在股份总数为67,921,412股。
截至2026年2月28日，公司股本总数保持不变。公司同时确认遵守香港联交所《上市规则》及相关法规的要求。公告由执行董事、首席财务官兼公司秘书柴海节签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.